Seoul’s Creative Heart

https://korean-electronics.com//inquiry

Seongsu-dong From Factory Floors to Seoul’s Creative Heart

Seongsu-dong’s transformation from an industrial backwater into one of Seoul’s most vibrant cultural districts stands as a defining example of urban regeneration. Once packed with shoemaking workshops, auto repair shops, and small factories, the neighborhood has evolved into a creative hub of fashion, cafés, technology firms, and experiential retail. Rather than erasing its past, Seongsu-dong rebuilt its future on preserved red brick warehouses, turning industrial heritage into cultural capital

The Industrial Roots That Shaped the Landscape
Seongsu-dong began its rise in the 1960s and 1970s when it was designated a semi-industrial zone. Shoemakers migrated here from central Seoul as rents climbed, and over time the district became South Korea’s main handmade shoe production cluster, housing more than a thousand workshops at its peak.
The neighborhood’s identity was defined by low rise red brick factories built for efficiency and durability. Their wide interiors and high ceilings were originally meant for machinery but later proved perfect for galleries, cafés, and creative studios. What was once purely functional architecture became the backbone of Seongsu-dong’s revival.

Saving Brick Buildings Instead of Replacing Them
While much of Seoul redeveloped into glass towers, Seongsu-dong’s industrial decline in the late 1990s preserved its factory structures. Large scale demolition never arrived, leaving behind a landscape of aging but character rich warehouses.
In the early 2010s, artists and entrepreneurs moved in, drawn by affordable rents and raw industrial aesthetics. Local government later reinforced preservation through programs encouraging red brick restoration, ensuring that new development would complement the historic look rather than erase it.

Seoul Forest and the Rise of a Creative Lifestyle Zone
The opening of Seoul Forest in 2005 accelerated Seongsu-dong’s transformation. The massive urban park dramatically improved livability, attracting residents, startups, and visitors. Shared offices and social enterprises settled nearby, bringing in young professionals who blurred the line between work and leisure.
Cafés, boutiques, and restaurants soon clustered around the park, creating a walkable lifestyle district where green space met creative commerce. Seoul Forest became both a recreational hub and a catalyst for cultural growth.

Repurposed Landmarks That Defined the New Identity
Iconic reused buildings anchored the neighborhood’s cultural reputation. Daelim Changgo transformed a former warehouse into a gallery and fashion venue, preserving raw brick walls and steel pillars as design features. Café Onion converted a decades old factory into one of Seoul’s most photographed cafés, keeping its worn textures and industrial charm.
LCDC Seoul pushed repurposing further by merging old auto shops and shoe factories into a multi level cultural complex built around a shared courtyard and rooftop views. These spaces showed how industrial heritage could become immersive cultural environments.

From Trend District to Global Retail Playground
By the mid 2020s, Seongsu-dong had become Seoul’s trendsetting epicenter. Global luxury brands launched experiential concept stores here, choosing the area’s youthful creative energy over traditional upscale districts. At the same time, pop up shops appeared constantly, transforming warehouses into short term showcases for fashion, beauty, food, and art.
This fast rotating retail culture turned the neighborhood into a living exhibition space where visitors encountered something new each week, fueling its reputation as Seoul’s most dynamic hotspot.

Balancing Growth With Tradition
Major corporations soon followed, relocating headquarters and building smart office complexes in Seongsu-dong. The district evolved into a new business hub alongside its cultural fame. However, rapid success pushed rents upward, forcing many traditional artisans, especially shoemakers, to leave.
To protect local character, authorities introduced sustainable development zones, limited franchise expansion, and revitalized Handmade Shoe Street as a cultural attraction celebrating the district’s roots.

A Future Built on Old Bricks
Looking toward 2030, large redevelopment projects aim to turn Seongsu-dong into a global innovation district with startup campuses and mixed use towers. Yet its greatest strength remains the coexistence of old and new. Red brick factories stand beside tech offices, and artisan workshops operate near luxury boutiques.
Seongsu-dong’s story proves that urban renewal does not require erasing history. By embracing its industrial past and adapting it for modern life, the neighborhood has become one of Seoul’s most authentic and dynamic districts, where creativity grows from the foundations of heritage.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Korea’s January Exports

https://korean-electronics.com//inquiry

Korea’s January Exports Hit a Record High of $65.85 Billion


 In the first month of the New Year, Korea’s exports reached a record high of $65.85 bil., fueled by a semiconductor boom. Semiconductor exports doubled compared to the same month of last year.
According to the Ministry of Trade, Industry and Energy (MOTIE), Korea’s exports last month reached $65.85 billion, a massive 33.9% increase year-on-year. Average daily exports, taking into account operating days, also rose 14.0% to $2.8 bil., a record high.
January imports were recorded at $57.11 bil., an 11.7% increase. Energy imports decreased by 11.9%, but non-energy imports increased by 18.4%.

With exports exceeding imports, the trade balance in January reached a surplus of $8.74 billion, a $10.71 billion increase year-on-year, marking the 12th consecutive month of surplus.
Exports of 13 of the 15 major export items increased. Of these, semiconductor exports reached $20.54 bil., a 102.7% year-on-year increase. While this represents a slight decrease from the all-time high of $20.8 bil of December last year, it still represents the second-highest performance on record.

The strong semiconductor performance was largely due to rising memory fixed prices driven by demand for artificial intelligence (AI) and data center infrastructure. Compared to the same month of last year, international memory fixed prices increased by 752% for DDR4 (8Gb), 661% for DDR5 (16Gb), and 334% for NAND (128Gb).
Wireless communication devices (USD 2.03 bil., up 66.9%) increased for the third consecutive month, while computers (USD 1.55 bil., up 89.2%) saw their fourth consecutive month of growth, driven by robust SSD exports fueled by growing demand for AI infrastructure. Displays (USD 1.38 bil., up 26.1%) also saw growth for the second consecutive month.

Automobile exports rose 21.7% to USD 6.07 bil., driven by increased operating days due to the Lunar New Year holiday being moved from January last year to February this year, and strong performance in eco-friendly vehicles such as hybrids and electric vehicles.
Conversely, petrochemical exports decreased 4.5% to USD 3.52 bil., impacted by lower export prices due to global oversupply.
By region, exports increased in seven of the nine major export markets, excluding Japan and the Commonwealth of Independent States (CIS).
Exports to the USA (USD 12.02 bil., up 29.5%) were sluggish in many categories, including automobiles, auto parts, and general machinery, due to tariffs. However, semiconductor exports showed growth, setting a new record for January.
Exports to ASEAN also increased by 40.7% to USD 12.11 bil., demonstrating the continued recovery in manufacturing and trade in ASEAN countries.
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

KINTEX

https://korean-electronics.com//inquiry

KINTEX: Developing a Global Space Competitiveness by Constructing its Third Exhibition Center

Opening a New Runway for K-Industry

KINTEX is currently constructing its third exhibition center, scheduled for completion in the second half of 2028. This project represents an infrastructure investment aimed at overcoming the structural limitations of the Korean exhibition industry, while also embodying a strategy to steadily attract large-scale global exhibitions and elevate KINTEX on the global stage.
With the completion of the third exhibition center, KINTEX’s total exhibition space will increase from 108,000 square meters to 170,000 square meters. It will also rise from 66th to the top 30 globally in terms of exhibition space, providing KINTEX with the physical capacity to simultaneously accommodate large-scale and multi-purpose exhibitions. This will effectively establish the foundation for KINTEX’s full-fledged entry into the global exhibition market.
For KINTEX, the construction of the third exhibition center is not simply an expansion project; it is a strategic decision that reflects the reality that the competitiveness of the nation’s exhibition industry hinges on the scale of its space. The exhibition center will function as an industrial platform where technology disclosure, market validation, and contract signing can occur simultaneously. It is not simply a space for promotion, but a space where business is completed.

Accordingly, the value of offline space in the exhibition industry is actually increasing even amid the proliferation of digital technology. As of 2025, the scale of the global exhibition industry reached approximately $60 billion, with an average annual growth rate of over 5%.
The problem, however, still lies in Korea’s spatial competitiveness. Exhibition powerhouses like the USA, China, and Europe are leading the global exhibition market with exhibition infrastructure spanning millions of square meters. In contrast, Korea’s total exhibition space is a mere 310,000 square meters, occupying a mere 0.7% of the global overall scale. Compared to its economic size, Korea’s exhibition infrastructure is significantly lagging behind. This gap in space availability is leading to a significant gap in Korea’s competitiveness in the hosting of exhibitions.

The construction of this third exhibition center aims to take this challenge to the next level. Beyond mere quantitative
expansion, it will be transformed into a smart exhibition center utilizing big data and artificial intelligence (AI). With the construction of the new center, visitor flow will be managed through data, further enhancing the efficiency of matching between participating companies and buyers. Furthermore, temperature, lighting, and power will be managed automatically. The goal is to transform all aspects of exhibition center operations into a data-driven system, thereby enhancing efficiency and productivity.

The opening of the GTX-A express train line has also improved accessibility to KINTEX. With the expansion of linked infrastructure, including anchor hotels, and multiplex buildings for parking, the whole area of KINTEX is expected to develop into a self-sufficient MICE complex combining exhibitions, lodging, transportation, and business.
KINTEX’s CEO Lee Min-woo described the construction of the third exhibition center as an expansion of Korea’s business runway, emphasizing, “Exhibition centers are economic infrastructure that connects industries and actualizes contracts. The third exhibition center will serve as a significant opportunity to broaden the physical foundation for domestic companies to compete in the global market.”

Major Exhibitions in 2026

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Premium Skincare Device

https://korean-electronics.com//inquiry

[INQ. NO. 2602E09] Healux Co, Ltd. is expanding its business into beauty devices, in addition to lifting threads. Its flagship device, HealfusionPRO, is a premium skincare device utilizing solution-based waterjet technology. The solution minimizes skin irritation while simultaneously removing impurities and improving skin condition.
HealfusionPRO features a 3D rotating tip, designed to provide three-dimensional care according to the skin’s curves. This allows the solution to be applied more evenly to the skin, and it focuses on providing a more precise treatment experience compared to the existing 2D devices.
The device is increasingly being adopted by dermatology departments and premium clinics in Korea. It is particularly popular among high-end clinics in the Gangnam and Cheongdam areas of Seoul, building brand trust through increased use.

Healux continues to achieve significant success in overseas markets. Currently, HealfusionPRO is being exported to Hong Kong, Turkey, the UK, and Mexico.
Healux is preparing to launch its Healfusion brand in the USA and Brazil. To this end, it is gradually developing product education materials and digital marketing contents tailored to the local markets. Furthermore, it is diversifying its business portfolio by expanding its export portfolio to include skin booster products like MESOGLORY.
This year, Healux plans to participate in major international exhibitions and conferences, starting with IMCAS Paris, followed by AMWC Monaco, Dubai Derma, Korea Derma, Cosmoprof Hong Kong, and the American Society of Medispa.
In particular, Healux plans to participate in the Be+Well exhibition in Las Vegas, USA, in June, marking the beginning of brand activities aimed at a full-scale entry into the U.S. market in the second half of the year.
Healux is a company providing various products and services in the medical aesthetics field, starting with the development and manufacturing of laser devices for skin treatment, and growing into a specialized company offering comprehensive anti-aging solutions. Founded in 2018 and headquartered in Seoul, Healux has expanded its global influence by distributing its products to approximately 60 countries worldwide.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Aesthetic Medical Devices

https://korean-electronics.com//inquiry

[INQ. NO. 2602E08] Chungwoo Medical, a specialized aesthetic medical device manufacturer with 25 years of experience, develops and manufactures energy-based medical devices, including radiofrequency (RF) and high-intensity focused ultrasound (HIFU) ― using proprietary technology.
With approximately 30% of its workforce dedicated to research and development and approximately 20% of its revenue reinvested in R&D, Chungwoo Medical has focused on advancing its products with clinical efficacy, safety, and user convenience in mind.

Leveraging this technological prowess, Chungwoo Medical’s products are currently supplied to over 70 countries worldwide, including those in Asia, Europe, the Middle East, and the Americas. The company is steadily securing key global certifications, including the EU’s MDR, the U.S. FDA, and Brazil’s ANVISA, thereby building its credibility in the international market.
At KIMES 2026, Chungwoo Medical plans to showcase its new aesthetic medical devices targeting the global market on an international stage, and to actively pursue overseas export sales and new distribution partners. During the exhibition, the company will conduct consultations tailored to each country’s distribution structure and regulatory requirements, based on product competitiveness, core technologies, and clinical data. It aims to establish mid- to long-term global partnerships by linking follow-up meetings and contract negotiations after the exhibition.
The APOLEX Tite, a key product to be showcased at the exhibition, is a medical device utilizing the Inside Monopolar Radiofrequency (IMR) method. Its design utilizes a patented, ultra-small temperature-sensing cannula to deliver high-frequency current to tissue to induce coagulation.
The 18g cannula minimizes the incision area, and a real-time temperature sensor enables energy control approximately 5°C before the set temperature is reached, ensuring a more stable treatment environment.

Furthermore, the device measures and controls tissue impedance in real time during the procedure, minimizing the impact on surrounding tissue and reducing the risk of charring or burns.
The ELLISYS SENSE is a medical device that uses high-frequency current to induce tissue coagulation. It features a double-shot design that delivers thermal energy to two skin layers in a single shot. It utilizes a vacuum suction system to maintain stable contact with the skin, and by controlling the needle insertion depth, it ensures even energy delivery to the target layer. Accordingly, this reduces treatment time, providing a more precise treatment environment.

The CONTLEX SENSE is a non-invasive, high-intensity focused ultrasound (HIFU) device featuring precise energy control using a magnetic cartridge. The two-way round-trip irradiation method was applied to increase the efficiency of the procedure. The two types of handpieces – line type and pen type – are supplied to enable flexible application according to the area and purpose of treatment.
Chungwoo Medical is expanding its global business into South America, the Middle East, some Asian nations, the Unites States, and Europe. By entering the market with FDA and CE certifications, the company plans to enhance brand credibility and expand its reach. Furthermore, it intends to strengthen its distribution network in South America and the Middle East to meet the growing demand for its non-invasive, energy-based devices.
Meanwhile, Chungwoo Medical plans to expand its reach with global buyers and medical professionals by participating in major international exhibitions, including IMCAS Paris, IMCAS America, IMCAS Asia, and Dubai Derma, following its participation in KIMES 2026. By launching R&D-driven new products and securing global certifications, the company plans to gradually strengthen its position as a leading K-aesthetic medical device brand.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

AI-Based Cervical Cancer Screening Solution

https://korean-electronics.com//inquiry

[INQ. NO. 2602E07] NTL Healthcare Co., Ltd, a medical device company specializing in the early diagnosis of female cancers, is expanding its business in the global market through diagnostic solutions that combine medical technology and artificial intelligence (AI).
Since its first foray into the field of gynecological cancer diagnosis in Korea in 1996 with the introduction of ‘Cervicography,’ an analog-based cervical cancer screening system, NTL Healthcare has continuously advanced its remote screening system and AI-based diagnostic technology.
NTL Healthcare has focused on improving the accuracy and accessibility of cervical cancer screening, focusing on developing technologies that can provide the same quality of diagnosis even in settings with inadequate existing medical infrastructure.
Based upon this accumulated technological expertise, NTL Healthcare is currently building a female disease diagnostic platform centered on its AI-based cervical cancer screening solution, ‘CerviCARE® AI.’
CerviCARE® AI is medical software that uses deep-learning-based AI to analyze cervical lesion images, complementing the subjective judgment of the diagnostician and providing standardized analysis results.
CerviCARE® AI is designed to capture cervical lesions externally, and then use AI to detect and analyze them to classify their condition, thereby assisting in determining subsequent treatment options. This reduces variation across testing environments and readers, thereby contributing to increased diagnostic efficiency.

Furthermore, the solution is designed to integrate with remote diagnostic systems to support rapid decisions, even when a second opinion from an expert is required. It is also meaningful in terms of improving medical accessibility and expanding the scope of women’s health care, as it can also be utilized in environments where traditional medical facilities are lacking.
NTL Healthcare currently exports its products to approximately 20 countries and has been gradually expanding its global presence, focusing on Asian countries such as Thailand, Mongolia, and Vietnam. Building on this momentum, it is also pursuing expansion into low- and middle-income countries (LMICs) and the European market.
Through its participation in this KIMES exhibition, NTL Healthcare is seeking to discover new business partners and expand global partnerships through direct consultations with domestic and international medical device buyers, distributors, and hospital officials. Through on-site demonstrations and consultations, NTL Healthcare plans to directly demonstrate the product’s functionality and usability, incorporating market needs and the latest trends into future product development and marketing strategies.

NTL Healthcare is prioritizing Japan, Indonesia, and Australia as its key markets, and is expanding collaboration opportunities in countries with a high level of acceptance of new medical technology.
In particular, CerviCARE® AI is a solution that can be utilized both in regions with limited medical infrastructure and advanced medical environments. Its strength is evaluated as its ability to simultaneously ensure standardization and speed in the process of diagnosis.
NTL Healthcare plans to continue participating in various domestic and international medical device exhibitions and academic events, including MEDICA 2026. Through these activities, NTL Healthcare aims to strengthen its networking with global medical experts and the industry persons concerned, and further promote the technology’s clinical value and potential applications.
Based on these activities, NTL Healthcare plans to continue expanding its services to provide more efficient and standardized medical services in the field of female cancer diagnosis.


 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Digital Healthcare Solutions

https://korean-electronics.com//inquiry

[INQ. NO. 2602E06] Miraclare is a company that develops and supplies digital healthcare solutions encompassing everything from oral and jaw health management to clinical environment care, leveraging its sensor technology and data analysis capabilities. It continues to expand its data-driven approach to healthcare, centered on electromyography (EMG) technology.
At the core of Miraclare’s solutions is precisely measuring and analyzing subtle movements that patients may not be aware of, such as temporomandibular jointmuscle activity during sleep, teeth grinding and clenching, and supplying such data to both medical professionals and users in a way that they can easily understand.
Miraclare has built a broad product portfolio, encompassing personal wearable devices, analysis equipment for hospitals and dental clinics, and medical consumables, striving for both technological excellence and practicality.
In particular, Miraclare is expanding its scope of application in clinical settings by developing customized care products, including eye protection patches, eye shields, and thermal care products, that prioritize hygiene, safety, and ease of use ― in consideration of repetitive medical environments.
In Korea, the company is introducing its ‘Goodeeps Monitoring’ primarily to local dental clinics, and is gathering real-use cases for hospitals and clinics. This service-based solution ― where patients borrow the device from the hospital, measure their sleep at home for two to three days, and then transmit the data to their medical practitioner’s account ― allowing medical professionals to utilize this data as objective consultation data, is gaining keen attention in the field.
Miraclare’s technological prowess is also gaining recognition in overseas markets. The personal wearable ‘Goodeeps’ achieved over 1,000% of its funding goal on the Taiwanese crowdfunding platform ZecZec, demonstrating market responsiveness.
Furthermore, Miraclare has signed a memorandum of understanding (MOU) with Ci Medical, Japan’s largest dental equipment distributor, and is pursuing an exclusive distribution agreement with the company, with annual sales of approximately KRW 630 billion. Through this agreement, Miraclare is establishing a distribution and sales base for Goodeeps and Goodeeps Monitoring products in Japan, while also securing substantial sales and clinical data.


 Teeth Grinding & Teeth Clenching Analysis Solution
At KIMES 2026, Miraclare will showcase its teeth grinding and teeth clenching analysis solution, Goodeeps Monitoring, to medical professionals and hospital staff, demonstrating its practicality and potential clinical application. The key objective of this exhibition is to clearly demonstrate that this rental monitoring system measures temporomandibular joint muscle activity during sleep and allows patients to utilize the results from their home tests for consultations and explanations at the hospital.
Miraclare’s primary target markets are Japan, Taiwan, Southeast Asia, and parts of Europe. Japan is a market with strong interest in data-driven medical solutions, and the company aims to collaborate with potential partners in the nation for specialized medical practices such as dentistry and ophthalmology, as well as Taiwan, with its high acceptance of digital healthcare products.

With an eye on Taiwan, Miraclare is pursuing market expansion through crowdfunding and collaboration with medical distribution partners. In Europe and Southeast Asia, the company plans to collaborate with local buyers and medical consumable distribution partners, focusing on eye protection and clinical environment care products for dental, ophthalmology, and surgical settings.
Following KIMES 2026, Miraclare plans to expand the adoption of Goodeeps Monitoring in hospitals and increase its global presence by participating in overseas medical exhibitions and academic events. Focusing on Japan, Taiwan, Southeast Asia, and the Middle East, Miraclare plans to expand its network with local buyers and hospital staff, and gradually implement product localization and certification procedures. In the long term, it plans to achieve sustainable growth in the global medical and healthcare market through an integrated portfolio that combines data-driven oral and jaw health management solutions and medical environmental care products.


 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Stem Cell Extraction System

https://korean-electronics.com//inquiry

[INQ. NO. 2602E05] Miracell Co., Ltd. is a stem cell company specializing in stem cell-based regenerative medicine, accumulating unparalleled technological prowess.
Miracell’s proprietary stem cell extraction system, Smart M-Cell, and its dedicated kit are medical devices approved by Korea’s Ministry of Food and Drug Safety as stem cell products. Having received FDA registration and CE certification, the system meets global regulatory standards and is characterized by their ability to extract high-quality multi-cells with maximized stem cell viability.
Smart M-Cell is a system that automatically extracts and concentrates stem cells from blood or bone marrow, achieving cell viability rates of up to 99%. It can simultaneously extract more than five key regenerative cell types, including stem cells, growth factors, white blood cells, and SDF-1α, making it ideal for customized regenerative medicine treatments tailored to specific treatment goals.
Currently, Smart M-Cell is used in over 600 hospitals and clinics in Korea and in over 40 countries worldwide.

Miracell’s technological prowess and reliability have been recognized through global deployments spanning Europe, the Middle East, Asia, and the Americas.
Smart M-Cell’s applications are expanding beyond knee joint treatment to include brain function enhancement, skin improvement, and cosmetic and plastic surgery procedures. Considering the importance of stem cell extraction systems, a key component in regenerative medicine, Smart M-Cell is considered a foundational technology that enhances treatment consistency and efficiency.
Miracell is also introducing the ‘Chroma M-Cell,’ a next-generation solution designed to maximize the effectiveness of stem cell treatment. Chroma M-Cell is the world’s first ringer bag-covered device that utilizes photobiomodulation technology to enhance cell vitality during stem cell ringer injection.
The device’s core function is to enhance cellular physiological activity and stabilize cell instability when exposed to the external environment by irradiating it with light of a specific wavelength. Four wavelengths — red, blue, yellow, and green — can be selected based on the treatment objective, enabling the product’s applications to be further expanded into diverse fields such as regenerative medicine, skin regeneration, and immune enhancement. Chroma M-cell, used in conjunction with Smart M-cell, is positioned as a complementary solution that elevates the effectiveness of stem cell treatment.
Miracell is actively targeting Russia, South America, China, and Japan as key target markets and is actively pursuing the global regenerative medicine market. The company is pursuing global standardization of Smart M-cell, focusing on countries where demand for stem cell treatment is rapidly growing due to aging populations and the rise of chronic diseases.

China and Russia, in particular, are considered markets with a high level of acceptance of alternative treatments, while South America is seen as a market with growing demand for combined aesthetic and regenerative medicine treatments. Japan, with its strong institutional support for regenerative medicine, is expected to have a high potential for early market penetration.
Miracell plans to actively promote Korea’s stem cell extraction technology, focusing on Smart M-Cell and Chroma M-cell, at major global exhibitions such as IMCAS (Paris), Dubai Stem Cell Congress, AAOS 2026, Dubai Derma 2026, INTERCHARM Moscow, and MEDICA (Düsseldorf). Through this, the company’s strategy is to verify its technological prowess, safety, and scalability on the international stage and further strengthen its position as a global platform company in the field of regenerative medicine.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Electroceutical-Based Pain Treatment Solution

https://korean-electronics.com//inquiry

[INQ. NO. 2602E04] Mediver Inc. is a medical device company specializing in electroceutical technology, leveraging medical science to enhance treatment accessibility and safety. Mediver’s mission, a combination of ‘Medical’ and ‘Version,’ embodies its mission to complement existing treatment methods and provide safer, more accessible options through electroceutical technology.
Since its founding in 2017, Mediver has built a competitive edge in the electroceutical field by internalizing the entire commercialization process, from R&D, to clinical trials, production, licensing, and sales.

Mediver has expanded its product portfolio by launching medical and aesthetic devices such as Pain Block, Pain Care, Cryion, PLAJET PRO, SONICool, and LINEUP ― in both domestic and international markets. Among these, Pain Block, a non-invasive electroceutical medical device based on scrambler therapy, has been recognized as a new medical technology by the Ministry of Health and Welfare. It is supplied to over 300 hospitals and clinics in Korea and has thus become its flagship product.
Pain Care is a compact, lightweight, portable electroceutical that provides pain relief through electrode patches without medication or injections. It is widely used in hospitals and clinics, sports rehabilitation centers, athlete training facilities, and home care settings. Its reusable design and simple operation are designed for both medical staff and users. Cryion, a medical combination stimulator, is being widely used for pain relief and rehabilitation.
In the field of aesthetic devices, the PLAJET PRO, which utilizes vacuum tube plasma technology, is used for improving skin conditions, reducing inflammation, and promoting tissue regeneration. Based on SCI papers-based research outcomes, it is being used in a variety of professional settings, including dermatology, plastic surgery, and aesthetic clinics. Its applications are expanding to include scalp and hair loss management, lymphatic circulation, and skin condition improvement.


 Pain Block has obtained medical device certification in Indonesia and Taiwan and is currently being exported to these nations, while approval procedures are underway for entry into other Southeast Asian markets such as Thailand and Vietnam. The PLAJET beauty device has secured PSE certification in Japan and CE certification in Europe, and SONICool and LINEUP are also expanding their presence in the global beauty device market ― through preparation for certifications per each nation.

Mediver plans to participate in KIMES 2026 to showcase its electroceutical-based pain treatment solutions and beauty device technology to domestic and international medical professionals, buyers, and distributors ― in order to expand its global network. At the exhibition, Mediver will share clinical applications and potential applications of non-pharmaceutical, non-invasive pain treatment, focusing on Pain Block and Pain Care. Furthermore, it will discuss distribution and collaboration opportunities in key overseas markets, including Asia, the Middle East, and the United States.
Mediver plans to use this exhibition to simultaneously promote the clinical value and marketability of electroceutical-based technology. It will also highlight the potential of medical professionals-centered multidisciplinary collaboration and digital healthcare platform integration, emphasizing product reliability and technological competitiveness. It also plans to expand the social applicability of electroceutical technology by discovering overseas partners and expanding exchanges with investors and related organizations.


 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Integrated Medical AI Platform

https://korean-electronics.com//inquiry

[INQ. NO. 2602E03] Founded in June 2022, maihub Corp. is a medical AI integrated platform company focused on creating an environment that facilitates easier and more efficient implementation and operation of AI solutions in the medical field.
After drawing attention to the fact that despite rapidly growing interest and demand for medical AI, complex procedures and operational burdens for practical application have been obstacles to its adoption. Therefore, maihub launched maiLink, an integrated medical AI platform ― based upon the slogan ‘Easy-to-Use Medical AI Solutions for Everyone.’
maiLink is designed to operate various diagnostic assistance medical AI solutions in a single environment by combining image normalization AI processing technology, AI integration technology for hospital system linkage, and medical information collection and analysis technology into a single platform.

This solution minimizes changes to the existing hospital IT environment through a hybrid approach that combines a mini PC-based on-premises server with a cloud AI server. Analysis results are integrated with EMR and PACS, thus improving the efficiency of interpretation and treatment flow. This approach aims to reduce the burden of AI adoption for medical institutions while simultaneously enhancing its practical application in clinical practice.
maihub is also strengthening its patient-centered services along with its platform expansion. Through packaged medical AI services and the AI-based analysis report maiReport, it provides personalized health information and has established an environment where patients can manage and understand their test results in a single location. Its features ― such as hospital registration via QR scan, health insurance data integration, and supplying of customized health content ― are aimed at improving the patient experience.
Two key models will be unveiled by maihub at KIMES 2026:
Firstly, mai:BoneAge, a bone age prediction AI fully integrated into the maiLink platform following its acquisition. Based on wrist X-ray images, it applies the Greulich-Pyle (GP) model to provide three priorities of bone ages, and provides the ‘My Child’s AI Growth Report,’ which visualizes predicted height and growth information. Cumulative reports by examination point allow for intuitive monitoring of growth changes and management points, supporting decision-making by medical staff and guardians.

Secondly, it offers a ‘Medical AI Customized Package’ tailored to the specific clinical specialties and operating environment of each medical institution. To reduce the complexity of solution selection and implementation, maihuboffers AI solutions in packaged form, enabling healthcare institutions to more quickly utilize AI solutions tailored to their needs.
maihub entered the Southeast Asian market by obtaining certifications from Malaysia (MDA) and Indonesia (BPOM) and continues to collaborate with major local hospital networks.
maihub demonstrated its platform competitiveness in the North American market through its participation in RSNA 2025. Based on the permission of FDA 510(k) earlier this year, maihub plans to enter the U.S. market in earnest and expand its business to Central and South America.

Southeast Asia, a region with limited infrastructure and specialized personnel relative to healthcare demand, is experiencing high demand for medical AI commercialization. Therefore, the company’s strategy is to expand collaborations centered on solution models optimized for the local environment.
maihub is building platform-centric infrastructure encompassing all aspects of clinical care through collaborations with domestic and international medical AI companies. By continuously enhancing its packaged medical AI solutions, it reinforces the unique value that only a platform can provide.
Taking advantage of KIMES 2026 as an opportunity, maihub plans to enhance operational efficiency in global medical settings, accelerate the commercialization of medical AI, and contribute to its overseas expansion, and increase international cooperation by domestic medical AI companies.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods